Renata Brizzolara
Genoa, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
A circulating cell population showing both M1 and M2 monocyte/macrophage surface markers characterizes systemic sclerosis patients with lung involvement.
Journal: Respiratory research
Published: May 04, 2018
Increase in circulating cells coexpressing M1 and M2 macrophage surface markers in patients with systemic sclerosis.
Journal: Annals of the rheumatic diseases
Published: April 24, 2018
Effects of CTLA4-Ig treatment on circulating fibrocytes and skin fibroblasts from the same systemic sclerosis patients: an in vitro assay.
Journal: Arthritis research & therapy
Published: March 20, 2018
Effects of selexipag and its active metabolite in contrasting the profibrotic myofibroblast activity in cultured scleroderma skin fibroblasts.
Journal: Arthritis research & therapy
Published: January 05, 2018
Dual endothelin receptor antagonists contrast the effects induced by endothelin-1 on cultured human microvascular endothelial cells.
Journal: Clinical and experimental rheumatology
Published: August 11, 2016
Effects of combined treatments with CTLA4-IG (abatacept), dexamethasone and methotrexate on cultured human macrophages.
Journal: Clinical and experimental rheumatology
Published: August 19, 2015
A method for counting monosodium urate crystals in synovial fluid.
Journal: Reumatismo
Published: May 05, 2015
Effects of macitentan and its active metabolite on cultured human systemic sclerosis and control skin fibroblasts.
Journal: The Journal of rheumatology
Published: January 17, 2015
CTLA4-Ig/CD86 interactions in cultured human endothelial cells: effects on VEGFR-2 and ICAM1 expression.
Journal: Clinical and experimental rheumatology
Published: August 25, 2014
Intracellular NF-kB-decrease and IKBα increase in human macrophages following CTLA4-Ig treatment.
Journal: Clinical and experimental rheumatology
Published: July 23, 2013
Last Updated: 09/26/2026